The Journal publishes Original Papers, Review Articles and Clinical Reports on research relating to the toxicity of chemicals and their mixtures at molecular, cellular, tissue, target organ and whole body level in vivo (by all routes of exposure) and in vitro/ex vivo. Focus is on all aspects of modern toxicology: studies of pharmacotoxicological and metabolic mechanisms, toxicogenomics and proteomics, pharmacokinetics, cytotoxicity, immunotoxicity, organ toxicity, developmental toxicity, carcinogenesis, mutagenesis, environmental toxicity and environmental health concerning humans (including epidemiological studies), predictive toxicology, risk assessment, environmental chemistry of pesticides and dioxins,forensic toxicology and alternative toxicity testing.
Why subscribe and read
The journal aims to provide the complete and reliable source of information on current developments in the field of toxicology and related disciplines.
The emphasis is on publishing quality articles rapidly and making them freely available to researchers worldwide. All published articles will be deposited immediately upon publication in widely and internationally recognized open access repository free of charge.
The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.
Interdisciplinary Toxicology (iTox) publishes quarterly and is devoted to the publication of research results in all areas of Toxicology and related scientific disciplines: /science/toxicology/itox/authors/scope/. The primary mission of iTox is to assist Central and Eastern European researchers in communicating their achievements to the global scientific community, nevertheless, contributions from other regions of the world are by no means excluded. The journal is peer-reviewed, in electronic-only format. The language of the journal is English.
Manuscripts preferred for publication in iTox are those which:
Contain original work - which is not published elsewhere in any medium by the authors or anyone else, and is not under consideration for publication in any other medium. This restriction does not apply to review articles.
Are focused on the core aims and scope of the journal - iTox is a scientific journal publishing fundamental research results from all fields of toxicology and related scientific disciplines.
Are clearly and correctly written - should contain all essential features of a complete scientific paper, should be written in a clear, easy to understand manner, and be readable for a wide audience.
Are written in English - should be clearly and grammatically written, in an easily readable style. Attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper (Please note that authors who are not native-speakers of English can be provided with help in rewriting their contribution in correct English).
iTox publishes research articles, communications, review papers and book reviews.
a) Research Articles
b) Rapid Communications – short reports on new and exciting results of high urgency. Sending us a report of significant interest, authors are asked to provide an explanation in their cover letter describing in detail why their contribution should be handled via rapid channel
c) Reviews – topical mini(reviews) as well as full critical reviews on important subjects reflecting new trends in chemistry are also included in this section
d) Book reviews
PEER REVIEW PROCESS
All manuscripts sent via e-mail receive individual identification codes. The Managing Editor then sends it to an appropriate Editor. However a submission may be declined by the Managing Editor without review, if deemed inappropriate for reasons other than scientific merit.
a) choice of reviewers The Editors of iTox, each responsible for different area of Toxicology, seek advice from experts of in the appropriate field. Research articles and communications are reviewed by a minimum of two reviewers, review papers by at least three.
b) suggestions from authors Authors are requested to suggest persons competent to review their manuscript. However please note that this will be treated only as a suggestion, and the final selection of reviewers is exclusively the Editor’s decision.
The Editors are fully responsible for decisions about manuscripts. The final decision whether to accept or reject a paper rests with them. The Managing Editor only communicates the final decision, and informs the authors about further processing. www.setox.eu/intertox
REVISED MANUSCRIPT SUBMISSION
When revision of a manuscript is requested, authors should return the revised version of their manuscript as soon as possible. Prompt action may ensure fast publication if a paper is finally accepted for publication in iTox. If it is the first revision of an article authors need to return their revised manuscript within 60 days. If it is the second revision authors need to return their revised manuscript within 14 days. If these deadlines are not met, and no specific arrangements for completion have been made with the Editor, the manuscript will be treated as a new one and will receive a new identification code along with a new registration date.
Authors will receive a pdf file with the edited version of their manuscript for final proofreading. This is the last opportunity to view an article before its publication on the journal web site. No changes or modifications can be introduced once it is published. Thus authors are requested to check their proof pages carefully against manuscript within 3 working days and prepare a separate document containing all changes that should be introduced. Authors are sometimes asked to provide additional comments and explanations in response to remarks and queries from the language or technical editors.
ONLINE FIRST SERVICE
Manuscripts accepted for publication are published on-line in so called Online First service as soon as they are ready for publication (that is when final proofreading is performed by authors, and all concerns are resolved). Final manuscripts for publication may appear on the Web 1-2 months prior to regular issue publication. Once a manuscript appears on the Web site it is considered as published.
After publication, the corresponding author is notified by email, and receives a pdf file with the published version of the manuscript.
If any errors are detected in the published material they should be reported to the Managing Editor. The corresponding authors should send appropriate corrected material to the Managing Editor via email. This material will be considered for publication in the earliest available issue of iTox.
TRANSFER OF COPYRIGHT AGREEMENT
A properly completed Transfer of Copyright Agreement must be provided for each submitted manuscript. Transfer of Copyrights Agreement should be signed, scanned and sent via email to the Managing Editor of the journal. Please read the terms of this agreement, print and then fll, sign and send a scanned document by email to the Managing Editor of this journal.
Editor-in-Chief: Prof. Miroslav Pohanka, PhD. DSc.
Editorial Advisory Board Arturo R. Anadon, Department of Toxicology and Pharmacology, Faculty of Veterinary Medicine, Spain Radomír Nosáľ, Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, Slovakia Russel J. Reiter, Department of Cellular and Structural Biology, The University of Texas Health Science Center, USA Christina Ruden, Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Sweden Marie Stiborová, Department of Biochemistry, Faculty of Science, Charles University, Czech Republic Aristidis M. Tsatsakis, Director Toxicology & Forencic Sciences Dept., Faculty of Medicine, University of Crete, Greece Martin F. Wilks, SCAHT - Swiss Centre for Applied Human Toxicology, Universität Basel, Switzerland
Editors General Toxicology, Pharmacology & Physiology Viktor Bauer, Slovakia Iveta Bernátová, Slovakia Felix Carvalho, Portugal Nancy Claude, France Robert D. Grubbs, USA Jaroslav Květina, Czech Republic Gabriela Nosáľová, Slovakia Thomas Weiser, Switzerland Michal Zeman, Slovakia
Environmental Toxicology Heidi Foth, Germany Jyrki Liesivuori, Finland Zdeňka Svobodová, Czech Republic
Carcinogenesis & Xenobiochemistry Pavel Anzenbacher, Czech Republic David R. Cool, USA Eva Horváthová, Slovakia Jana Navarová, Slovakia Ladislav Šoltés, Slovakia Jan Vondráček, Czech Republic
In Vitro Toxicology Štefan Bezek, Slovakia Helena Kandarova, USA Miguel A. Sogorb, Spain Miloň Tichý, Czech Republic
Military Toxicology James B. Lucot, USA Jiří Kassa, Czech Republic Ahmet Korkmaz, Turkey
Developmental Toxicology Eva Cecilie Bonefeld-Jørgensen, Denmark Ingrid Brucknerová, Slovakia Peter G. Fedor-Freybergh, Slovakia Eduard Ujházy, Slovakia
Language Editor Magda Kouřilová, Slovakia
Technical Editor Mojmir Mach, Slovakia
Publisher De Gruyter Poland Bogumiła Zuga 32A Str. 01-811 Warsaw, Poland